Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the Society of Toxicologic Pathology (STP).
The Executive Committee of the Society of Toxicologic Pathology (STP) appointed an ad hoc task force to devise and recommend a standard list of tissues to be evaluated histopathologically in repeat-dose toxicity and carcinogenicity studies that are used to support the registration of new pharmaceutical products. The recommended tissue list is intended to be a minimum core list that can be used for all types of repeat-dose toxicity and carcinogenicity studies, regardless of route of administration, species or strain of mammalian laboratory animal, duration, or class of drug to be tested. The resulting recommendations of the task force, presented here, were subsequently reviewed by the STP membership and endorsed by the STP Executive Committee.
Bregman
Carla L
CL
Bristol-Myers Squibb Company, Syracuse, New York, USA.
Adler
Rick R
RR
Morton
Daniel G
DG
Regan
Karen S
KS
Yano
Barry L
BL
D026683:Advisory Committees; D000818:Animals; D000830:Animals, Laboratory; D015197:Carcinogenicity Tests / Q000379:methods / Q000592:standards*; D005260:Female; D006287:Health Planning Guidelines; D008297:Male; D010336:Pathology / Q000379:methods*; D012958:Societies, Scientific; D036401:Toxicity Tests, Chronic / Q000379:methods / Q000592:standards*; D014116:Toxicology / Q000379:methods / Q000592:standards*; D014481:United States